
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
Anna Godi, Troy J. Kemp, Lígia A. Pinto, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 12, pp. 1940-1945
Open Access | Times Cited: 18
Anna Godi, Troy J. Kemp, Lígia A. Pinto, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 12, pp. 1940-1945
Open Access | Times Cited: 18
Showing 18 citing articles:
Molecular epidemiology of human papillomavirus variants in cervical cancer in India
Neeti Sharma, Harish Changotra, Manpreet Kaur
The Indian Journal of Medical Research (2025) Vol. 160, pp. 531-551
Open Access
Neeti Sharma, Harish Changotra, Manpreet Kaur
The Indian Journal of Medical Research (2025) Vol. 160, pp. 531-551
Open Access
Scientific approaches to defining HPV vaccine‐induced protective immunity
Matti Lehtinen, Pierre Van Damme, Simon Beddows, et al.
International Journal of Cancer (2025)
Open Access
Matti Lehtinen, Pierre Van Damme, Simon Beddows, et al.
International Journal of Cancer (2025)
Open Access
Vaccine escape challenges virus prevention: The example of two vaccine‐preventable oncogenic viruses
Wenjie Qu, Long Sui, Yanyun Li
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 7
Wenjie Qu, Long Sui, Yanyun Li
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 7
Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection
Gathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Gathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
A novel C-terminal modification method enhanced the yield of human papillomavirus L1 or chimeric L1-L2 virus-like particles in the baculovirus system
Mingrao Ma, Baicheng Xia, Zhirong Wang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 4
Mingrao Ma, Baicheng Xia, Zhirong Wang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 4
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes
Anna Godi, Dolcibella Boampong, Busayo Elegunde, et al.
Journal of Virology (2020) Vol. 94, Iss. 24
Open Access | Times Cited: 10
Anna Godi, Dolcibella Boampong, Busayo Elegunde, et al.
Journal of Virology (2020) Vol. 94, Iss. 24
Open Access | Times Cited: 10
Genetic variability analysis of human papillomavirus 58: Novel sublineage identification and persistent infection association
Yan Wang, Yingxin Gong, Qi Zhou, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 3
Yan Wang, Yingxin Gong, Qi Zhou, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 3
Mutation Profiles, Glycosylation Site Distribution and Codon Usage Bias of Human Papillomavirus Type 16
Wei Liu, Junhua Li, Hongli Du, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1281-1281
Open Access | Times Cited: 7
Wei Liu, Junhua Li, Hongli Du, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1281-1281
Open Access | Times Cited: 7
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine
Kavita Panwar, Anna Godi, Clementina Cocuzza, et al.
Vaccine (2022) Vol. 40, Iss. 9, pp. 1198-1202
Open Access | Times Cited: 5
Kavita Panwar, Anna Godi, Clementina Cocuzza, et al.
Vaccine (2022) Vol. 40, Iss. 9, pp. 1198-1202
Open Access | Times Cited: 5
Recombination in Papillomavirus: Controversy and Possibility
Yingxin Gong, Long Sui, Yanyun Li
Virus Research (2022) Vol. 314, pp. 198756-198756
Closed Access | Times Cited: 4
Yingxin Gong, Long Sui, Yanyun Li
Virus Research (2022) Vol. 314, pp. 198756-198756
Closed Access | Times Cited: 4
Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibody
Zhiping Wang, Daning Wang, Jie Chen, et al.
Science Bulletin (2023) Vol. 69, Iss. 4, pp. 512-525
Open Access | Times Cited: 2
Zhiping Wang, Daning Wang, Jie Chen, et al.
Science Bulletin (2023) Vol. 69, Iss. 4, pp. 512-525
Open Access | Times Cited: 2
The clinical and epidemiological impacts of whole genomic sequencing on bacterial and virological agents
Sarah Timsit, Laurence Armand-Lefèvre, Jérôme Le Goff, et al.
Infectious Diseases Now (2023) Vol. 54, Iss. 2, pp. 104844-104844
Closed Access | Times Cited: 2
Sarah Timsit, Laurence Armand-Lefèvre, Jérôme Le Goff, et al.
Infectious Diseases Now (2023) Vol. 54, Iss. 2, pp. 104844-104844
Closed Access | Times Cited: 2
Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
Catia Sias, Valerio Guarrasi, Claudia Minosse, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 4
Catia Sias, Valerio Guarrasi, Claudia Minosse, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 4
Mapping HPV 16 Sub-Lineages in Anal Cancer and Implications for Disease Outcomes
Daniel Guerendiain, Laila Sara Arroyo Mühr, Raluca Grigorescu, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3222-3222
Open Access | Times Cited: 3
Daniel Guerendiain, Laila Sara Arroyo Mühr, Raluca Grigorescu, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3222-3222
Open Access | Times Cited: 3
Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China
Wenjie Qu, Chen Hua, Yaping Wang, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 411-411
Open Access
Wenjie Qu, Chen Hua, Yaping Wang, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 411-411
Open Access
Variant analysis of human papillomavirus type 52 in Iranian women during 2018−2020: A case‐control study
Parvin Jalali‐Alhosseini, Zabihollah Shoja, Somayeh Jalilvand
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access
Parvin Jalali‐Alhosseini, Zabihollah Shoja, Somayeh Jalilvand
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access
Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay
Kavita Panwar, Anna Godi, Clementina Cocuzza, et al.
MethodsX (2022) Vol. 9, pp. 101776-101776
Open Access | Times Cited: 2
Kavita Panwar, Anna Godi, Clementina Cocuzza, et al.
MethodsX (2022) Vol. 9, pp. 101776-101776
Open Access | Times Cited: 2
Mutation Profiles, Glycosylation Site Distribution and Codon Usage Bias of HPV16
Wei Liu, Junhua Li, Hongli Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Wei Liu, Junhua Li, Hongli Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1